1Catalona WJ, Smith DS, Ratliff TI.,et al. Measurement of prostate- specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991 Apr 25 ;324(17 ) :1156 -1161. 被引量：1
4Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol,2004,172(4 Pt 1 ) :1297 -1301. 被引量：1
5Vessella RL, Lange PH, Partin AW, et al. Probability of prostate cancer detectionbased on results of a multicenter study using the AxSYM free PSA and total PAS assay. Urology,2000,55(6) :909 -914. 被引量：1
6Mikolajczyk SD, Naya Y, Fritsche HA, et al. Evaluation of precursor prostate - specific antigen isoform ratios in the detection of prostate cancer. Urol Oncol. 2005,23( 1 ) :16 -21. 被引量：1
7Xiao Z, Adam BL, Cazares LH, et al. Quantitation of serum prostate -specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res. 2001 Aug 15 ;61 (16) :6029 -6033. 被引量：1
8Kurek R, Nunez G, Tselis N, et al. Prognostic value of combined " triple" - reverse transcription - PCR analysis for prostate - specific antigen, human kallikrein 2, and prostate - specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Clin Cancer Res. 2004 Sep 1 ;10(17) :5808 -5814. 被引量：1
9Ghossein RA, Osman I, Bhattacharya S, et al. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. Diagn Mol Pathol, 1999,8 (2) :59 -65:216 -218. 被引量：1
10Cohen P, Peehl DM, Lamson G,et al. Insulin- like growth factors (IGFs), IGF receptors, and IGF -binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab, 1991,73 (2) :401 -407. 被引量：1
2Holly J. Insulin-like growth factor-I and new opportunities for cancer prevention. Lancet, 1998,351: 1373-1375. 被引量：1
3Chan J M, Stampfer M J, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer rsk: Apospective sudy. Sience, 1998, 279:563-566. 被引量：1
4Cutting C, Meadows K, Holly J, et al. Serum IGFs and prostate cancer. Molecular Pathology, 2001, 54:41-44. 被引量：1
5Palmvist R, Hallmans G, Rinaldi S,et al. Plasma insulinlike factor insulin-like growth factor protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. GUT, 2002,50 : 642- 646. 被引量：1
6Hampel O Z, Kattan M W, Yang G, et al. Quantitative imnlunohistochemocal analysis of insulin-like graloth factor binding protain-3 in human prostatic adenocarcinoma:a prognostic study. J Urol, 1998, 159:2220 -2225. 被引量：1
7Nam R K,Diamandis E P,Toi A,et al. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen. J Clin Oncol, 2000, 18:1036 -1042. 被引量：1
8Charles A, Calenoff E, Ditlow C, et al. A new serum testing method for detection of prostate cancer. J Urol,2002,168:93-99. 被引量：1
9Ismall A H, Pollak M, Behlouli H, et al. insulin-like growth factor and insulin-like growth factor binding protain-3 for prostatic cancer detection in patients undergoing prostate biopsy. J Urol, 2002, 168: 2426-2430. 被引量：1
